CHLORPROMAZINE TANNATE |
LARGACTIL |
MEGAPHEN |
CHLORPROMAZINE HIBENZATE |
SONAZINE |
SKF-2601A |
J2.794D |
CHLORPROMAZINE PHENOLPHTHALINATE |
NSC-167745 |
ELMARIN |
CHLORPROMAZINE |
THORAZINE |
NSC-226514 |
3-(2-CHLORO-10H-PHENOTHIAZIN-10-YL)-N,N-DIMETHYL-1-PROPANAMINE |
N-(3-DIMETHYLAMINOPROPYL)-3-CHLOROPHENOTHIAZINE |
CPZ |
LARGACTIL® |
3-(2-CHLOROPHENOTHIAZIN-10-YL)-N,N-DIMETHYL-PROPAN-1-AMINE |
CHLORPROMAZINE HCL |
THORAZINE® |
rxcui:2403 |
chemidplus:50-53-3 |
drugbank:00477 |
chembl:CHEMBL71 |
pubchem.compound:2726 |
Drug Categories | phenothiazines with aliphatic side-chain |
Drug Groups | investigational |
Drug Categories | adrenergic alpha-1 receptor antagonists |
Drug Categories | adrenergic alpha-antagonists |
Drug Categories | adrenergic antagonists |
Drug Categories | agents producing tachycardia |
Drug Categories | agents that produce hypertension |
Drug Categories | agents that reduce seizure threshold |
Drug Categories | anticholinergic agents |
Drug Categories | antidepressive agents |
Drug Categories | cholinesterase inhibitors |
Drug Categories | cytochrome p-450 cyp2d6 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2e1 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a inducers |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inducers |
Drug Categories | cytochrome p-450 cyp3a4 inducers (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a4 substrates (strength unknown) |
Drug Categories | cytochrome p-450 enzyme inducers |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | dopamine d2 receptor antagonists |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | histamine antagonists |
Drug Categories | histamine h1 antagonists |
Drug Categories | hyperglycemia-associated agents |
Drug Categories | muscarinic antagonists |
Drug Categories | neurotoxic agents |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | photosensitizing agents |
Drug Categories | qtc prolonging agents |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | serotonin 5-ht1 receptor antagonists |
Drug Categories | serotonin 5-ht2 receptor antagonists |
Drug Categories | serotonin agents |
Drug Categories | serotonin receptor antagonists |
antagonist (inhibitory) |
Endogenous Drug? | False |
Specific Action of the Ligand | Antagonist |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
blocker (inhibitory) |
Direct Interaction? | False |
Endogenous Drug? | False |
Specific Action of the Ligand | None |
binder |
antagonist (inhibitory) |
Endogenous Drug? | False |
Specific Action of the Ligand | Inverse agonist |
binder |
antagonist (inhibitory) |
Specific Action of the Ligand | Inverse agonist |
Endogenous Drug? | False |
binder |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
Specific Action of the Ligand | Antagonist |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
binder |
antagonist (inhibitory) |
Mechanism of Interaction | Serotonin 2a (5-HT2a) receptor antagonist |
Direct Interaction | yes |
Specific Action of the Ligand | Inverse agonist |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
binder |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Endogenous Drug? | False |
Specific Action of the Ligand | Antagonist |
CHLORPROMAZINE | DrugBank Drug Name |
50-53-3 | CAS Number |
Aminazine | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
C367 | NCI drug code |
CHEMBL71 | ChEMBL Drug ID |
D01ZII | TTD Drug ID |
CHLORPROMAZINE | GuideToPharmacology Ligand Name |